{"paper_id": "65abb6b718f4e84054335e5383ee0955cb6b0718", "metadata": {"title": "Characterization of acute acro-ischemic lesions in non-hospitalized patients: a case series of 132 patients during the COVID-19 outbreak", "authors": [{"first": "D", "middle": [], "last": "Fernandez-Nieto", "suffix": "", "affiliation": {}, "email": ""}, {"first": "J", "middle": [], "last": "Jimenez-Cauhe", "suffix": "", "affiliation": {}, "email": ""}, {"first": "A", "middle": [], "last": "Suarez-Valle", "suffix": "", "affiliation": {}, "email": ""}, {"first": "O", "middle": ["M"], "last": "Moreno-Arrones", "suffix": "", "affiliation": {}, "email": ""}, {"first": "D", "middle": [], "last": "Saceda-Corralo", "suffix": "", "affiliation": {}, "email": ""}, {"first": "A", "middle": [], "last": "Arana-Raja", "suffix": "", "affiliation": {}, "email": ""}, {"first": "D", "middle": [], "last": "Ortega-Quijano", "suffix": "", "affiliation": {}, "email": ""}, {"first": "Jimenez-Cauhe J", "middle": [], "last": "Suarez-Valle", "suffix": "", "affiliation": {}, "email": ""}, {"first": "A", "middle": [], "last": "", "suffix": "", "affiliation": {}, "email": ""}, {"first": "Moreno-Arrones", "middle": ["O"], "last": "", "suffix": "", "affiliation": {}, "email": ""}]}, "abstract": [], "body_text": [{"text": "To the Editor, 26 The Coronavirus Disease 2019 has been associated to several skin 27 manifestations, including widespread urticaria, erythematous rash and varicella-like 28 exanthem 1,2 . Ischemic and ecchymotic acral lesions have also been described in patients 29 with severe forms of COVID-19, as a manifestation of clotting disorders 3 . Coincident After the evaluation of clinical images, we could describe two different patterns of acute 50 acro-ischemic lesions, which can overlap ( Table 1 ). The chilblain-like pattern was 51 present in 95 patients (72.0%). It is characterized by red to violet macules, plaques and 52 nodules, usually at the distal aspects of toes and fingers ( Figure 1A, B, C) . The 53 erythema multiforme-like pattern was present in 37 patients (28.0%). It is characterized 54 by rounded erythematous macules and vesicles that tend to coalesce. Compared to 55 classical erythema multiforme, individual lesions are smaller (less than 1cm diameter).", "cite_spans": [{"start": 15, "end": 17, "text": "26", "ref_id": null}], "ref_spans": [{"start": 491, "end": 498, "text": "Table 1", "ref_id": "TABREF0"}, {"start": 690, "end": 706, "text": "Figure 1A, B, C)", "ref_id": null}], "section": ""}, {"text": "It does not usually present typical targetoid lesions and tends to be less widespread 57 (Figure 2A , B, C). Only 2 of 37 patients (5.4%) also presented lesions at other sites of 58 the body, including elbows, knees and ears. ", "cite_spans": [], "ref_spans": [{"start": 89, "end": 99, "text": "(Figure 2A", "ref_id": null}], "section": "56"}], "bib_entries": {"BIBREF0": {"ref_id": "b0", "title": "Cutaneous manifestations in COVID-19: a first perspective", "authors": [{"first": "S", "middle": [], "last": "Recalcati", "suffix": ""}], "year": null, "venue": "J Eur Acad", "volume": "80", "issn": "", "pages": "", "other_ids": {}}, "BIBREF2": {"ref_id": "b2", "title": "Varicella-like exanthem as a specific COVID-82 19-associated skin manifestation: multicenter case series of 22 patients", "authors": [{"first": "A", "middle": ["V"], "last": "Marzano", "suffix": ""}, {"first": "G", "middle": [], "last": "Genovese", "suffix": ""}, {"first": "G", "middle": [], "last": "Fabbrocini", "suffix": ""}], "year": null, "venue": "Journal", "volume": "", "issn": "", "pages": "", "other_ids": {}}, "BIBREF6": {"ref_id": "b6", "title": "Acute acro-ischemia in the child at the time of COVID-19", "authors": [{"first": "F", "middle": [], "last": "Mazzotta", "suffix": ""}, {"first": "T", "middle": [], "last": "Trocoli", "suffix": ""}], "year": null, "venue": "Eur. J", "volume": "88", "issn": "", "pages": "", "other_ids": {}}, "BIBREF9": {"ref_id": "b9", "title": "COVID-19): a Meta-Analysis", "authors": [], "year": 2019, "venue": "Coronavirus Disease", "volume": "", "issn": "", "pages": "", "other_ids": {"DOI": ["10.1111/bjh.16725"]}}}, "ref_entries": {"FIGREF0": {"text": "a case series of 132 patients during the COVID-19 outbreak. 3 Authors: Fernandez-Nieto D, MD a , Jimenez-Cauhe J, MD a , Suarez-Valle A, MD a , 4 Moreno-Arrones OM, MD, PhD a , Saceda-Corralo D, MD, PhD a , Arana-Raja, A, of interest: The authors have no conflict of interest to declare 16 Funding sources: The article has no funding source 17 All human and animal studies are approved by an Institutional Review Board.", "latex": null, "type": "figure"}, "FIGREF1": {"text": ": SARS-CoV-2; skin; virus; ischemia; chilblain; erythema multiforme; 24 acro-ischemia.", "latex": null, "type": "figure"}, "FIGREF2": {"text": "30with the COVID-19 pandemic, similar acro-ischemic lesions have being described in 31 healthy young patients 4 . However, its clinical implication and relation to COVID-19 32 remain unclear.33    We designed a retrospective study of general consultations from 05 March to 15 April34 2020 in Spain. Inclusion criteria were the presence of skin lesions as the reason for 35 consultation, collection of clinical pictures and informed consent. Exclusion criteria 36 included non-acral skin lesions and lack of clinical data. 37 From a total of 346 initial patients, 132 fulfilled selected criteria. Patients' data is shown 38 in Table 1. Mean age was 19.9 years (range 1-51 years). 54 patients (40.9%) had close 39 contact with a confirmed COVID-19 patient, 28 patients (21.2%) had close contact with 40 a health worker, and 19 patients (14.4%) were clinically diagnosed with COVID-19. 41 None of the patients had COVID-19 pneumonia or specific medication. 16 patients 42 started with COVID-19 symptoms before the skin lesions, with a mean latency time of 43 9.2 days (range 3-30 days), and 3 patients started at the same time. Mean duration of the 44 skin lesions was 8.7 days (range 2-24 days). In 11 patients, a real-time reverse 45 transcription polymerase chain reaction (rt-PCR) test for severe acute respiratory 46 syndrome coronavirus 2 (SARS-CoV-2) was performed from a nasopharyngeal swab, after the onset of skin lesions. 2 patients (18.1%) were tested positive. Serological 48 assays were not performed.", "latex": null, "type": "figure"}, "FIGREF3": {"text": "60prothrombin time are associated with poor prognosis 5 . Acral, true ischemic lesions have 61 been described in severely-ill COVID-19 patients, manifesting a disseminated 62 intravascular coagulation. There is an increasing concern about clinical implications of 63 acute acro-ischemic lesions in asymptomatic or mildly symptomatic patients. The 64 patients in this study did not develop COVID-19 pneumonia or any other complication.65The latency time between COVID-19 symptoms and skin manifestations, and the low 66 positive rate for nasopharyngeal swabs suggest that it represents a late manifestation of 67 SARS-CoV-2 infection. Whether they represent a coagulation disorder or a 68 hypersensitivity reaction is yet to be known.", "latex": null, "type": "figure"}, "FIGREF4": {"text": "Chilblain-like acro-ischemia. A) Ecchymotic plaques and nodules with a 114 bruising appearance over the distal aspects of toes. B) Confluent erythemato-violaceous 115 diffuse plaques sparing some toes and the dorsal feet. C) Close-up view of the lateral 116 and plantar aspects of toes. Erythema multiforme-like acro-ischemia. A) Erosion and crust formation 118 over dusky plaques in the dorsal aspects of digits. A Koebner phenomenon is present 119 over the hallux valgus. B) Circular lesions, some of them with a targetoid appearance 120 over the plantar surface. C) Confluent vesicles over a dusky area.", "latex": null, "type": "figure"}, "TABREF0": {"text": "Clinical characteristics of patients with acro-ischemic lesions.", "latex": null, "type": "table", "html": "<html><body><table><tr><td>\u00a0</td><td>Clinical pattern of acral lesions </td><td>\u00a0</td><td>\u00a0</td></tr><tr><td>Characteristic </td><td>Chilblain-like </td><td>Erythema multiforme-\n</td><td>Total </td><td>p </td></tr><tr><td>n=95 (72.0%) </td><td>like </td><td>n=132 </td><td>value* </td></tr><tr><td>\u00a0</td><td>\u00a0</td><td>n=37 (28.0%) </td><td>\u00a0</td><td>\u00a0</td></tr><tr><td>Age, mean (range), years </td><td>23.4 (2-56) </td><td>12.2 (1-29) </td><td>19.9 (1-56) </td><td>&lt;0.00</td></tr><tr><td>\u00a0</td><td>\u00a0</td><td>\u00a0</td><td>-Male: 71 </td><td>\u00a0</td></tr><tr><td>Sex </td><td>-Male: 49 (51.6%) -Female: 46 (48.4%) </td><td>-Male: 22 (59.4%) -Female: 15 (40.6%) </td><td>(53.8%) -Female: 61 </td><td>0.415 </td></tr><tr><td>\u00a0</td><td>\u00a0</td><td>\u00a0</td><td>(46.2%) </td><td>\u00a0</td></tr><tr><td>COVID-19 symptoms </td><td>-19 patients (25.0%) </td><td>-6 patients (16.2%) </td><td>-18 patients (13.6%) </td><td>0.618 </td></tr><tr><td>-Hands: 33 (34.7%) </td><td>-Hands: 8 (21.6%) </td><td>-Hands: 41 (31.1%) </td><td>0.144 </td></tr><tr><td>Location of skin lesions </td><td>\u00a0</td><td>\u00a0</td><td>-Feet: 108 </td><td>\u00a0</td></tr><tr><td>-Feet: 73 (76.8%) </td><td>-Feet: 35 (94.6%) </td><td>(81.8%) </td><td>0.018 </td></tr><tr><td>\u00a0</td><td>-Digital: 87 (91.6%) </td><td>-Digital: 33 (89.2%) </td><td>-Distal: 120 (90.9%) </td><td>0.738\u2020 </td></tr><tr><td>Distribution of skin lesions </td><td>-Dorsal: 23 (24.2%) </td><td>Dorsal: 12 (32.4%) </td><td>-Dorsal: 35 (26.5%) </td><td>0.336 </td></tr><tr><td>-Ventral: 3 (3.2%) </td><td>-Ventral: 15 (40.6%) </td><td>-Ventral: 18 (13.6%) </td><td>&lt;0.001 </td></tr><tr><td>-Heels/wrists: 12 (12.6%) </td><td>-Heels/wrists: 10 (27.0%) </td><td>-Heels/wrists: 22 (16.7%) </td><td>0.046 </td></tr><tr><td>Duration of skin lesionsmean (range), days </td><td>-Other: 0 </td><td>-Other: 2 (5.4%) </td><td>-Other: 2 (1.5%) </td><td>0.077\u2020 </td></tr><tr><td>, 9.2 (3-24) </td><td>7.4 (2-15) </td><td>8.7 (2-24) </td><td>0.019 </td></tr></table></body></html>"}}, "back_matter": [{"text": "The authors would like to thank all the health workers that have been relentlessly 72 fighting against COVID-19 in Spain. Special thanks for their help in data collection to:", "cite_spans": [], "ref_spans": [], "section": "71"}]}